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ABSTRACT 
 Shape Memory Polymer (SMP) Foams for Bone Defect Repair. (May 2014)  
 
Olivia J. George 
Department of Biomedical Engineering 
Texas A&M University 
 
Research Advisor: 
Dr. Melissa A. Grunlan 
Department of Biomedical Engineering  
 
Thermoresponsive shape memory polymers (SMPs) are stimuli-sensitive materials that return 
to their permanent shape from a fixed temporary shape in response to heat. Porous SMP 
foams exhibit distinct properties that make them well suited for certain applications in the 
biomedical field. However, current SMP foams are restricted to a limited group of organic 
polymer systems. Inorganic-organic foams containing polydimethylsiloxane (PDMS) and 
poly(ε-caprolactone) (PCL) segments prepared from diacrylated PCLn-block-PDMSm-block-
PCLn have recently been reported by our research group. These SMPs exhibit excellent 
biological, morphological and mechanical properties that may be attractive for “self-fitting” 
scaffolds to heal cranio-maxillofacial (CMF) bone defects whereby application of warm 
saline triggers the SMP to expand and conformably fit into a defect before cooling and 
hardening at body temperature. To enhance the resorption capacity of the scaffolds, the 
PDMS component may be substituted with a degradable poly(silyl ether fumarate) (PSEF) 
segment. Herein, two synthetic strategies toward PCLn-block-PSEFm-block-PCLn were 
explored. Synthetic approaches toward PSEF-diacrylate (i.e. without PCL shape memory 
ability) are also investigated. 
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NOMENCLATURE 
 
BDSB  1,4-bis(dimethylsilyl)benzene  
CaSO4  calcium sulfate 
CMF   cranio-maxillofacial 
CSD   critically sized defect 
DCM   methylene chloride 
DMAP  4-dimethyl amino pyridine 
KOH  potassium hydroxide 
N2  nitrogen 
Na2SO4 sodium sulfate 
NaOH  sodium hydroxide 
PCL   poly(ε-caprolactone) 
PDMS  polydimethylsiloxane 
PPF   poly(propylene fumarate) 
PSEF   poly(silyl ether fumarate) 
rbf  round bottomed flask 
RT  Room Temperature 
SCPL   solvent casting-particulate leaching 
TE   Tissue Engineering 
Tg   glass transition temperature 
Tm   melting transition temperature  
Ttrans   transition temperature 
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CHAPTER I 
INTRODUCTION 
 
Cranio-maxillofacial bone defects  
Neurocranium and facial bones comprise the cranio-maxillofacial (CMF) skeleton that supports 
and protects the brain, nerves, vasculature, and soft cephalic tissues [1]. According to the 
National Institute of Dental and Craniofacial Research, craniofacial injuries motivate 20 million 
visits to emergency departments each year [2]. CMF damage may be the result of congenital 
deformity, trauma, infection or tumorectomy, and can produce permanent disfigurement and 
dysfunction if healing does not occur properly [1]. In particular, critically sized defects (CSD) 
above a threshold wound size will not heal spontaneously during the lifetime of the patient and 
thus require surgical intervention to guide new bone formation [3]. Repair of CSDs typically 
involves use of autologous bone grafts harvested from the patient’s fibula, iliac crest, scapula or 
radius [1, 4 - 6]. However, this approach is associated with significant drawbacks, including 
limited availability, donor site morbidity, and complex grafting procedures [1, 5]. Failure to 
appropriately shape the autograft to match defect topology can result in graft resorption [6]. 
Thus, alternative strategies that can overcome these limitations are of primary interest. 
 
Tissue engineering  
Tissue engineering (TE) represents a promising alternative to treat CMF bone defects [7]. An 
ideal bone scaffold candidate should conform intimately to edges of the defect to permit 
osseointegration, be osteoconductive (i.e. allowing the infiltration of bone tissue) and be 
bioactive (i.e. promoting bonding with the surrounding bone tissue and permitting osteogenic 
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cell attachment and differentiation) [4]. Many current tissue engineering systems fail to fully 
address these design criteria. For example, in situ forming hydrogels and bone ceramics have 
been widely explored for their ability to fill irregular defect geometries [8]. However, they lack 
the structural and mechanical characteristics necessary for bone defect applications. In particular, 
bone cements are brittle and often demonstrate poorly controlled porosity [4]. Hydrogels often 
exhibit variable cure times and lack sufficient mechanical strength [8]. 
 
Shape memory polymers 
Shape memory polymers (SMPs) are stimuli-responsive materials that can undergo reversible 
shape change in response to an external stimulus [9]. Their unique dual-shape capability has 
prompted their investigation in a variety of biomedical applications including intelligent sutures 
for wound closure, self-deploying stents to prevent stroke, and embolic sponges for aneurysm 
treatment  [9 - 12]. 
 
The shape memory effect is attributed to “netpoints” and “switching segments” that work 
together. The netpoints may be physical (intermolecular) or chemical (covalent) crosslinks that 
define the permanent shape, while the switching segments impart shape memory ability, 
allowing the SMP to fix a temporary shape and subsequently recover a permanent shape upon 
heating [9, 13 - 14]. In the case of thermoresponsive SMPs, the external stimulus is heat. Upon 
cycling through a transition temperature (Ttrans), the SMP is temporarily deformed (T > Ttrans) 
and fixed into a rigid temporary shape (T < Ttrans) before recovering a permanent shape upon 
heating (T > Ttrans) [13]. This process is represented in Figure 1. 
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The use of SMPs in self-fitting bone defect scaffold applications has recently been proposed 
[16]. Porous, thermoresponsive SMPs with sharp, tunable transition temperatures are of 
particular interest as these could also provide a minimally invasive alternative to current grafting 
approaches and as well as overcome significant limitations of hydrogel or ceramic TE scaffold 
designs. In this capacity, a porous SMP could be implanted into a defect in a confined volume 
and triggered to expand and conformably fit with the surrounding tissue upon application of 
warm saline. Once cooled to body temperature, the scaffold would become relatively hardened, 
“locking” with the osseous environment to form a tight junction necessary for defect healing 
(Figure 2). 
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Figure 1: The entropically driven shape memory process: (a) polymer switching segments 
are easily deformed and fixed into a temporary elongation, (b), upon cooling. The switching 
segments permit recovery of the permanent shape (c) upon heating. Adapted from [15]. 
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Figure 2: The SMP is “programmed” into a temporary shape and implanted into the defect at T < Ttrans. Heating 
with warm saline (T > Ttrans) triggers deployment. Upon cooling to body temperature (T < Ttrans), the scaffold 
hardens and “locks” with the surrounding tissue. 
  
Hybrid SMPs 
Poly(ε-caprolactone) (PCL)-based SMP systems have gained recent attention in biomedical 
applications due to PCL’s degradability, elasticity, and biocompatibility [12]. PCL crystalline 
domains act as switching segments with a melting transition temperature (Tm) serving as the 
Ttrans of the SMP. The Tm of PCL can be tuned from 43-60 °C with adjustments in molecular 
weight, rendering the polymer effective in in vivo applications that require minimal heating. 
Incorporation of additional polymeric segments, including polyurethanes and poly(n-butyl 
acrylate), in the polymer backbone has been investigated as a route to tune SMP scaffold 
properties [12]. However, these designs are largely limited to organic-only SMP systems. To 
realize the potential of SMPs, hybrid systems that incorporate both organic and inorganic 
components should be considered, as these tend to impart superior control of physical properties 
versus homopolymer systems [5, 17]. In particular, inclusion of a silicon-containing polymer 
segment could afford unique degradation, thermal and mechanical properties useful in bone 
defect applications. 
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Innovation 
We recently prepared porous thermoresponsive SMP “foams” based on macromers containing 
poly(ε-caprolactone) (PCL) and polydimethylsiloxane (PDMS) segments, diacrylated PCLn-
block-PDMSm-block-PCLn, using a revised solvent casting-particulate leaching (SCPL) approach 
that includes salt fusion and photocrosslinking [13 – 14, 18].  By tailoring salt particle size, 
degree of salt fusion and macromer concentration, SMP foams with excellent shape fixity (Rf), 
shape recovery (Rr) and highly tunable pore interconnectivity, pore size, and modulus were 
achieved. Furthermore, addition of a mussel-inspired polydopamine coating was shown to 
increase hydroxyapatite formation (i.e. bioactivity [19]) and enhance the capacity of the SMP to 
support osteoblast adhesion, proliferation and osteogenesis [18]. 
 
These properties align well with the requirements of an effective TE bone substitute. Yet, 
modifications in backbone structure could further improve scaffold degradation [20]. In 
particular, substitution of a degradable poly(silyl ether fumarate) (PSEF) segment for the non-
degradable PMDS softening segment could enhance the scaffold’s capacity for resorption in 
vivo. While PSEF’s exhibit low glass transition temperatures (Tg’s) similar to PDMS, these 
segments possess labile silyl ether (Si-O-C) functionality that degrades within weeks to months. 
Added hydrophilicity and crosslinking potential afforded by fumarate groups make PSEF 
particularly versatile [21]. Herein, routes to achieve diacrylated PSEF as well as diacrylated 
PCLn-block-PSEFm-block-PCLn were developed and initial syntheses executed. 
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CHAPTER II 
METHODOLOGY 
Polymer synthesis 
Two synthetic routes to prepare AcO-PCLn-block-PSEFm-block-PCLn-OAc and AcO-PSEFm-
OAc macromers were developed and are shown in full in Figures 3 and 4. 
 
 
 
 
Figure 3: First proposed strategy toward AcO-PSEF-OAc and AcO-PCLn-block-PSEFm-block-PCLn-OAc 
macromer syntheses. 
“Route 1” 
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Route 1: Synthesis and purification of bis(2-hydroxypropyl) fumarate        
Bis(2-hydroxypropyl) fumarate intermediate may be prepared as described in [21]: Diethyl 
fumarate (196.6 g) and propylene glycol (259.4 g) are combined (1:3 molar ratio) in a 1L three-
necked round bottom flask (rbf) equipped with a Teflon-coated stir bar. The system is purged 
under nitrogen (N2) at a stir rate of 150 r.p.m. Hydroquinone (0.25 g, 2.3 x 10-3 mol) and ZnCl2 
(1.55 g, 1.1 x 10-2 mol) are added to the reaction flask connected to a condenser and the stir rate 
increased to 300 r.p.m. The flask is heated in a silicone oil bath at 110 °C for 30 min. After 30 
min, the temperature is increased to 120 °C for 30 min, then to 130 °C. The reaction is allowed 
to proceed until approximately 90 % of the theoretical yield of ethanol (95 g) has been collected 
Figure 4: Second proposed strategy as an alternative route toward AcO-PSEF-OAc and AcO-PCLn-block-
PSEFm-block-PCLn-OAc macromer syntheses. 
 
“Route 2” 
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in the receiving flask before cooling to room temperature (RT) under N2. Figure 5 depicts the 
setup for this reaction.   
 
 
 
 
 
 
 
 
 
 
To purify bis(2-hydroxypropyl) fumarate, methylene chloride (DCM) is added to the crude 
product for a total solution volume of 800 mL. The solution is transferred to a 2-liter separatory 
funnel and 1.85 % HCl added such that the acid and macromer solutions are at a volume ratio of 
1:1. The mixture is agitated several times before allowing the phases to separate. After 10 min, 
the polymer phase is collected. This procedure is repeated twice with double-distilled water 
replacing the 1.85 % HCl; and twice with brine solution. 
 
To dry bis(2-hydroxypropyl) fumarate, sodium sulfate is slowly added while stirring with a 
magnetic Teflon stir bar until sodium sulfate aggregates become apparent. Stirring is maintained 
for 30 min followed by filtration through a Büchner funnel (ashless filter paper). The filtrate is 
transferred into a 1-liter rbf and DCM is removed under reduced pressure. 
Figure 5: The setup for bis(2-hydroxypropyl) fumarate synthesis.  
	  	   Temperature 
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Ethyl ether washes are performed in a 2 liter Erlenmeyer flask by slowly pouring the bis(2-
hydroxypropyl) fumarate solution into 1 liter ethyl ether over ice while stirring. The ether phase 
is decanted and the product is dissolved in 300 mL DCM. Solvents are removed under reduced 
pressure at 40 °C and the purified product is achieved upon drying under high vacuum at RT for 
8 h and subsequent N2 purging. 
 
Route 1: Preparation of PSEF from bis(2-hydroxypropyl) fumarate 
 
 
[Protocol to be finalized] 
 
 
Route 1: Preparation of OH-PCLn-block-PSEFm-block-PCLn-OH macromers 
Attachment of PCL-diol to PSEF is achieved via a ring opening polymerization similar to [22]: 
PSEF and ε-caprolactone are combined in a m:2n molar ratio in the presence of a tin catalyst 
(0.11 mmol). The reaction is then stirred in a rbf equipped with a rubber septum and magnetic 
Teflon stir bar for 24 h at 145 °C under N2. After cooling to RT, the crude product is dissolved in 
a minimal amount of chloroform (CHCl3) and precipitated twice in excess cold (~10 °C) 
methanol before drying under vacuum at 45 °C for 20 h. 
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Route 1: Acrylation of HO-PCLn-block-PSEFm-block-PCLn –OH and PSEF 
HO-PCLn-block-PSEFm-block-PCLn-OH (or PSEF) polymer end groups may be converted into 
photosensitive acrylate groups in the presence of acryloyl chloride. The macromer (20 g) is 
dissolved in DCM (120 mL) in a 250 mL rbf equipped with a Teflon stir bar. “1 piece” of 4-
dimethyl amino pyridine (DMAP) is added to the reaction flask and the solution is purged under 
N2 for 5 min at 260 r.p.m. Triethylamine and acryloyl chloride are slowly added to the reaction 
flask in a molar ratio of 2:4:1 to HO-PCLn-block-PSEFm-block-PCLn-OH (or PSEF), and the 
flask is stirred under N2 for 30 min. The system is then taken off N2, positioned under a 
condensation tube and heated to 50 °C. Reaction conditions are maintained for 20 h. 
 
DCM is removed under reduced pressure and the product is washed with ethyl acetate (135 mL) 
to remove triethylamine hydrochloride salts. The mixture is gravity filtered through ashless filter 
paper. Solvents are removed from the filtrate under reduced pressure. The polymer is then re-
dissolved in DCM (140 mL) and washed with (13.5 mL) 2 M K2CO3 (aq). Following separation, 
the organic layer is collected, dried with anhydrous MgSO4, and gravity filtered. DCM is 
removed under reduced pressure to achieve the purified product. 
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Route 2: Synthesis and purification of bis(2-hydroxypropyl) fumarate    
Alternatively, bis(2-hydroxypropyl) fumarate may be synthesized from propylene oxide and 
fumaric acid in a reaction modified from [23]. The setup for this reaction is shown in Figure 6.   
 
 
 
    
 
 
 
 
 
 
 
 
 
 
The day before starting the reaction, pyridine is dried over KOH, and 2-butanone and propylene 
oxide are dried over 4Å molecular sieves. Dry 2-butanone (200 mL) and 0.0016 mol 
hydroquinone are added to a 1L 3-neck rbf and stirred at 300 rpm. Fumaric acid (116 g, 1 mol) is 
added to the reaction vessel via funnel before attaching a coiled condenser and drying tube. Dry 
pyridine (2.7 mL) is added directly to the reaction mixture via micropipette. Propylene oxide 
(160 mL, 2.29 mol) in 160 mL dry 2-butanone (1:1 vol) is carefully added to an addition funnel 
Figure 6: Apparatus for “Route 2” bis(2-hydroxypropyl) 
fumarate synthesis.   
Mechanical 
stirring 
assembly 
Addition 
funnel CaSO4- 
containing 
drying tube 
Coiled 
condenser 
Temperature 
controller 
Temperature 
probe 
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clamped to the rbf. The reaction vessel is sealed with Keck clips and heated to 75 °C for 
approximately 1 h. The addition funnel is then carefully opened such that propylene oxide enters 
the vessel at a drop rate of 1 drop/s. Reaction conditions are maintained for 16 h before cooling 
to RT for purification. After the reaction has cooled, the dropping funnel and coiled condenser 
are detached from the flask and the distillation apparatus shown in Figure 7 is assembled while 
stirring is maintained.  
 
 
 
 
 
 
 
 
 
 
The reaction mixture is reheated to 85 °C and unreacted propylene oxide is allowed to vaporize 
for 1 h. An aspiration connection is substituted for the CaSO4 drying tube, and 2-butanone is 
distilled (approx. 1 h). Stirring is maintained while the vessel is allowed to cool to RT for 30 
min. The product is washed three times with 500 mL hexane and dissolved in DCM. Three 
washes with 300 mL 6:4 solution of 0.2 M NaOH:brine are performed, followed by a 300 mL 
brine wash. Purified bis(2-hydroxypropyl) is isolated upon drying with anhydrous Na2SO4, 
filtering through a Büchner funnel (ashless filter paper), and rotary evaporation overnight.  
Mechanical 
stirring 
assembly 
CaSO
4
-
containing 
drying tube 
Temperature 
controller 
  
Temperature 
probe 
Condenser 
Distillation 
adapter 
wrapped in Al foil 
Receiving flask 
in ice bath 
Vacuum 
takeoff 
adapter 
Figure 7: Setup for “Route 2” bis(2-hydroxypropyl) fumarate purification.   
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Route 2: Preparation of PSEF from bis(2-hydroxypropyl) fumarate 
PSEF synthesis is expected to follow a cross-dehydrocoupling reaction modified from [24 - 26] 
whereby bis(2-hydroxypropyl) fumarate (slight excess) and 1,4-bis(dimethylsilyl)benzene 
(BDSB) are combined in a Schlenk flask with 0.25 mol% of 10 wt% palladium on activated 
carbon as a catalyst at RT.  After rapid evolution of hydrogen, the temperature is raised to 100°C 
and maintained for 24 h. The catalyst is removed by filtration on Celite with THF as an eluent. 
Precipitation in cold methanol, followed by drying in vacuo at RT yields the purified product. 
 
Route 2: Preparation of OH-PCLn-block-PSEFm-block-PCLn-OH macromers 
This step is expected to follow identically the procedure outlined for the corresponding step in 
“Route 1” above. 
 
Route 2: Acrylation of HO-PCLn-block-PSEFm-block-PCLn –OH and PSEF 
This step is expected to follow identically the procedure outlined for the corresponding step in 
“Route 1” above. 
 
Characterization 
NMR 
1H NMR spectra are recorded on a Mercury 300 spectrometer (300MHz) with CDCl3 as an 
internal standard. 
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CHAPTER III 
RESULTS 
1H NMR 
The first step of “Routes 1” and “2” were performed.  In the first attempt, “Route 1” produced a 
viscous oligomeric product rather than the expected bis(2-hydroxypropyl) fumarate intermediate. 
This may be explained by slight temperature fluctuations in the reaction vessel that allowed 
undesirable transesterification reactions to occur [23]. “Route 2” yielded the desired intermediate 
(xn~1) with the 1H NMR spectra below (Figure 8) that is consistent with that previously reported 
[23]. 
 
 
 
 
 
 
 
 
 
0	  1	  2	  3	  4	  5	  6	  7	  8	   PPM 
 
Figure 8: Nuclear magnetic resonance spectra of bis(2-hydroxypropyl) fumarate   
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4 
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   19 
CHAPTER IV 
CONCLUSION 
 
Exceptional biological, morphological and mechanical properties recently observed in inorganic-
organic SMPs suggest their utility in bone defect repair applications. Introduction of a silyl ether-
fumarate (PSEF) segment could further enhance a PCL-based SMP’s resorption capacity by 
nature of its hydrolytically labile backbone. Moreover, tailoring the relative length of this 
segment would also manipulate mechanical properties of the resulting scaffolds. Herein, two 
independent strategies were developed toward the synthesis of a PSEF-containing SMP and the 
first step of each is evaluated. Diacrylated PSEF macromers may be also produced (i.e. without 
PCL switching segments) to yield useful macromers to produce scaffolds, albeit without shape 
memory behavior. “Route 1” was found to yield an oligomeric intermediate in the first step 
whereas “Route 2” yielded the bis(2-hydroxypropyl) fumarate intermediate as desired. The 
higher molecular weight intermediate observed in “Route 1” could be of interest in later stages as 
a method of tuning scaffold degradation properties. In future stages, the diacrylated polymers 
will be crosslinked to produce a library of SMPs with tunable degradation profiles. 
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